Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2.
Kunschner
Lara
L
Drexel University College of Medicine, Pittsburgh, PA, USA.
Scott
Thomas F
TF
D001921:Brain / Q000187:drug effects* / Q000473:pathology* / Q000503:physiopathology; D005260:Female; D005911:Gliosis / Q000276:immunology / Q000473:pathology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000008:administration & dosage*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008231:Lymphopenia / Q000188:drug therapy / Q000276:immunology; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications; D009413:Nerve Fibers, Myelinated / Q000276:immunology / Q000473:pathology; D009457:Neuroglia / Q000473:pathology / Q000648:ultrastructure; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage; D020127:Recovery of Function / Q000187:drug effects / Q000276:immunology; D016896:Treatment Outcome
D007376:Interleukin-2; D011993:Recombinant Fusion Proteins